Related Experiment Video
Updated: Jun 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Preventing stroke in patients with atrial fibrillation
1Yale Clinical Trials Office, Yale University School of Medicine, New Haven, Conn 06511, USA. Michael.Ezekowitz@yale.edu
Warfarin significantly reduces stroke risk in high-risk atrial fibrillation patients. Aspirin is effective for those with lower stroke risk, offering a tailored approach to prevention.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation affects a significant portion of the elderly population, increasing stroke risk.
- Stroke prevention in atrial fibrillation is a critical clinical challenge.
Purpose of the Study:
- To evaluate evidence for warfarin and aspirin in preventing stroke in atrial fibrillation patients.
- To synthesize data from randomized trials on antithrombotic therapy.
Main Methods:
- Systematic review of prospective, randomized trials (1966-1999).
- Inclusion of placebo-controlled studies, secondary prevention trials, and comparative studies.
- Analysis of warfarin monotherapy, aspirin monotherapy, and combination therapy.
Main Results:
- Stroke risk is heterogeneous, increasing with age and comorbidities like hypertension and diabetes.
- Warfarin use reduces stroke risk from 4.3-12%/year to 1.2-4%/year in high-risk patients.
- Low-risk patients (<65 years) have a 1%/year stroke risk without therapy.
Conclusions:
- Warfarin provides the most substantial stroke protection for high-risk atrial fibrillation patients.
- Aspirin demonstrates adequacy in managing stroke risk for low-risk populations.
More Related Videos
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pericarditis IV: Nursing Management
Rheumatic Heart Disease IV: Nursing Management
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions
Cardiomyopathy III: Hypertrophic Cardiomyopathy

